Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique
- PMID: 28282648
- PMCID: PMC5547744
- DOI: 10.1097/OLQ.0000000000000574
Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique
Abstract
Background: Research has shown that the distance to the nearest immunization location can ultimately prevent someone from getting immunized. With the introduction of human papillomavirus (HPV) vaccine throughout the world, a major question is whether the target populations can readily access immunization.
Methods: In anticipation of HPV vaccine introduction in Mozambique, a country with a 2015 population of 25,727,911, our team developed Strategic Integrated Geo-temporal Mapping Application) to determine the potential economic impact of HPV immunization. We quantified how many people in the target population are reachable by the 1377 existing immunization locations, how many cannot access these locations, and the potential costs and disease burden averted by immunization.
Results: If the entire 2015 cohort of 10-year-old girls goes without HPV immunization, approximately 125 (111-139) new cases of HPV 16,18-related cervical cancer are expected in the future. If each health center covers a catchment area with a 5-km radius (ie, if people travel up to 5 km to obtain vaccines), then 40% of the target population could be reached to prevent 50 (44-55) cases, 178 (159-198) disability-adjusted life years, and US $202,854 (US $140,758-323,693) in health care costs and lost productivity. At higher catchment area radii, additional increases in catchment area radius raise population coverage with diminishing returns.
Conclusions: Much of the population in Mozambique is unable to reach any existing immunization location, thereby reducing the potential impact of HPV vaccine. The geospatial information system analysis can assist in planning vaccine introduction strategies to maximize access and help the population reap the maximum benefits from an immunization program.
Conflict of interest statement
Conflict of Interest: None declared.
Figures
Similar articles
-
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.Vaccine. 2015 May 7;33 Suppl 1:A135-42. doi: 10.1016/j.vaccine.2014.12.031. Vaccine. 2015. PMID: 25919154
-
Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.BMC Public Health. 2014 Nov 26;14:1222. doi: 10.1186/1471-2458-14-1222. BMC Public Health. 2014. PMID: 25424716 Free PMC article.
-
The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique.Vaccine. 2016 Jul 29;34(35):4161-4165. doi: 10.1016/j.vaccine.2016.06.065. Epub 2016 Jun 29. Vaccine. 2016. PMID: 27372153 Free PMC article.
-
[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].Ned Tijdschr Geneeskd. 2009;153:A356. Ned Tijdschr Geneeskd. 2009. PMID: 19930733 Review. Dutch.
-
Implementation of human papillomavirus immunization in the developing world.Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Vaccine. 2012. PMID: 23199963 Review.
Cited by
-
High-resolution disease maps for cancer control in low-resource settings: A spatial analysis of cervical cancer incidence in Kampala, Uganda.J Glob Health. 2022 Apr 23;12:04032. doi: 10.7189/jogh.12.04032. eCollection 2022. J Glob Health. 2022. PMID: 35493778 Free PMC article.
-
A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.Vaccine. 2021 Nov 5;39(46):6796-6804. doi: 10.1016/j.vaccine.2021.05.033. Epub 2021 May 25. Vaccine. 2021. PMID: 34045101 Free PMC article.
-
Using Simulation Modeling to Guide the Design of the Girl Scouts Fierce & Fit Program.Obesity (Silver Spring). 2020 Jul;28(7):1317-1324. doi: 10.1002/oby.22827. Epub 2020 May 7. Obesity (Silver Spring). 2020. PMID: 32378341 Free PMC article.
References
-
- Loharikar A, Dumolard L, Chu S, et al. Status of new vaccine introduction—worldwide, September 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1136–1140. - PubMed
-
- 2015 global summary [database online] Geneva: World Health Organization; 2015. WHO vaccine-preventable diseases: monitoring system.
-
- Markowitz LE, Tsu V, Deeks SL, et al. Human papillomavirus vaccine introduction—the first five years. Vaccine. 2012;30(Suppl 5):F139–F148. - PubMed
-
- Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program. Vaccine. 2014;32:320–326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
